We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Abbott today announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) has granted national reimbursement for the company's MitraClip therapy to treat patients with mitral regurgitation